Cargando…
Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells
Docetaxel is a useful chemotherapeutic agent for the first-line treatment of hormone-refractory prostate cancer. Abnormal expression of Bcl-2 is commonly found in cancer cells, which increases their anti-apoptotic potency and chemo-resistance. We investigated the effects of Bcl-2 expression status o...
Autores principales: | OGURA, TAKEHARU, TANAKA, YOSHIYUKI, TAMAKI, HIROKI, HARADA, MAMORU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864052/ https://www.ncbi.nlm.nih.gov/pubmed/27082738 http://dx.doi.org/10.3892/ijo.2016.3482 |
Ejemplares similares
-
Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition
por: Tamaki, Hiroki, et al.
Publicado: (2014) -
Transition from Caspase-dependent to Caspase-independent Mechanisms at the Onset of Apoptotic Execution
por: Samejima, Kumiko, et al.
Publicado: (1998) -
Activation of Pro-apoptotic Caspases in Non-apoptotic Cells During Odontogenesis and Related Osteogenesis
por: Svandova, Eva, et al.
Publicado: (2018) -
Apoptotic Protease Activating Factor 1 (Apaf-1)–Independent Cell Death Suppression by Bcl-2
por: Haraguchi, Misako, et al.
Publicado: (2000) -
Nrz but not zBcl-xL antagonizes Bcl-wav pro-apoptotic activity in zebrafish
por: Prudent, Julien, et al.
Publicado: (2014)